ABT Articles, Abbott Laboratories

Abbott's (NYSE: ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomi...

Abbott (NYSE: ABT) announced that Lingo and Libre Rio, two of its glucose monitoring system, have received FDA clearance. Lingo and Libre Rio are b...

A California federal judge has reportedly allowed litigation to proceed against Abbott Laboratories (NYSE:ABT) regarding its Glucerna shakes and nu...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Dutch Bros Inc. (NYSE:BROS). On May 7, Dutch Bros posted bett...

The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it coul...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, th...

Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying ...

U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bul...

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesd...